CJC-1295 with DAC

CJC-1295 with DAC — Research Peptide

CJC-1295 with DAC, also known as CJC/DAC / CJC-1295 DAC, is a synthetic modified ghrh analogue / endocrine research peptide studied in laboratory research involving GHRH receptor pharmacology, peptide-protein binding and modified peptide stability. It is of scientific interest for controlled investigation of its associated molecular and biochemical systems.

Scientific Profile

• Peptide Name: CJC-1295 with DAC

• Also Known As: CJC/DAC / CJC-1295 DAC

• Molecular Formula: C₁₆₅H₂₆₉N₄₇O₄₆

• Classification: Synthetic modified GHRH analogue / endocrine research peptide

• Primary Research Target / System: Growth hormone-releasing hormone receptor (GHRH-R)

• Primary Research Areas: Ghrh receptor pharmacology, peptide-protein binding and modified peptide stability

Research Applications

CJC-1295 with DAC is used as an experimental research material in studies examining GHRH receptor pharmacology, peptide-protein binding and modified peptide stability.

• GHRH receptor pharmacology

• GHRH-associated signalling

• Peptide-receptor interaction

• Drug Affinity Complex (DAC) research

• Peptide-protein binding

• Modified peptide stability

• Structure-activity relationships

• Analytical characterization

Its defined chemical identity and established research context make CJC-1295 with DAC a useful laboratory material for investigating growth hormone-releasing hormone receptor (ghrh-r) and associated molecular pathways.

Research Classification

CJC-1295 with DAC is presented exclusively as a laboratory research material. Product information is provided for scientific identification and research reference purposes and does not represent therapeutic, medical, nutritional, diagnostic or performance claims.

For laboratory research purposes only. Not represented as a drug, therapeutic product, dietary supplement or veterinary product.